ETFis Series Trust I - Virtus Biotech ETF (ARCA: BBP)
Financials · Capital Markets · US
$101.31
+0.94% today · +50.6% 1Y
ETFis Series Trust I - Virtus Biotech ETF (ARCA: BBP) operates in the Capital Markets industry within the Financials sector. The company is valued at $106.38M.
Over the last twelve months the share price has gained 50.6%, trading between 62.93 and 105.21.
BBP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $106.38M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- $105.21
- 52-week low
- $62.93
- Avg volume (3M)
- —
- Shares outstanding
- 1.05M
- Employees
- —
- Next earnings
- —
About ETFis Series Trust I - Virtus Biotech ETF
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
- ISIN
- US26923G2021
- Founded
- 2014
- Listed since
- Dec 17, 2014
- Exchange
- NYSE Arca
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.31T | $378.24 | +0.44% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $703.71 | +0.39% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $893.67B | $769.31 | +0.39% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $821.60B | $765.72 | +0.41% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $487.14B | $713.44 | +0.36% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $378.44B | $87.50 | +0.38% |
| Morgan StanleyNYSE: MS | $336.42B | $214.20 | +3.25% |
| The Goldman Sachs Group, Inc.NYSE: GS | $314.66B | $1,039.28 | +3.73% |
Figures last refreshed Aug 18, 2026.